This study has revealed that a course of 10‐Hz rTMS treatment spanning 18 days not only ameliorated motor recovery in post‐stroke mice but also instigated an enhancement in glutamatergic synaptic transmission, alongside elevated levels of AMPARs, vGlut1, and integrin α3. This evidence concerns the gene SLC17A7 and Stroke.